Set back to Alzheimer vaccine studies.
Birmingham
Karen
K
Frantz
Simon
S
D000276:Adjuvants, Immunologic / Q000009:adverse effects; D000544:Alzheimer Disease / Q000276:immunology / Q000628:therapy*; D023582:Alzheimer Vaccines / Q000009:adverse effects*; D016229:Amyloid beta-Peptides / Q000009:adverse effects*; D017322:Clinical Trials, Phase II as Topic; D004345:Drug Industry / Q000191:economics; D006801:Humans; D007249:Inflammation / Q000209:etiology / Q000276:immunology; D007449:Investments
C437846:AN-1792; D000276:Adjuvants, Immunologic; D023582:Alzheimer Vaccines; D016229:Amyloid beta-Peptides